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Abstract
Muscle growth and repair rely on two main mechanisms – myonuclear accre-
tion and subsequent protein accumulation. Altering the ability of muscle resi-
dent stem cells (satellite cells) to progress through their myogenic lineage can
have a profound effect on lifetime muscle growth and repair. The use of the
histone deacetylase (HDAC) inhibitor, butyrate, has had positive outcomes on
the in vitro promotion of satellite cell myogenesis. In animal models, the use of
butyrate has had promising results in treating myopathic conditions as well as
improving growth efficiency, but the impact of dietary butyrate on satellite cells
and muscle growth has not been elucidated. We investigated the impact of
tributyrin, a butyrate prodrug, on satellite cell activity and muscle growth in a
piglet model. Satellite cells from tributyrin-treated piglets had altered myogenic
potential, and piglets receiving tributyrin had a ~40% increase in DNA:protein
ratio after 21 days, indicating the potential for enhanced muscle growth. To
assess muscle growth potential, piglets were supplemented tributyrin (0.5%)
during either the neonatal phase (d1–d21) and/or the nursery phase (d21–d58)
in a 2 9 2 factorial design. Piglets who received tributyrin during the neonatal
phase had improved growth performance at the end of the study and had a
~10% larger loin eye area and muscle fiber cross-sectional area. Tributyrin
treatment in the nursery phase alone did not have a significant effect on muscle
growth or feed efficiency. These findings suggest that tributyrin is a potent pro-
moter of muscle growth via altered satellite cell myogenesis.
Introduction
Postnatal muscle growth and repair rely on the ability of
satellite cells, muscle-resident stem cells, to activate, prolif-
erate, and fuse into growing myofibers (Seale et al. 2000;
Dumont et al. 2015). During the neonatal stage of life, the
fractional rate of protein synthesis contributing to muscle
growth is highest (Davis and Fiorotto 2009), marked by
increased satellite cell activation, proliferation (Allbrook
et al. 1971; Campion et al. 1981), and myonuclear accre-
tion (Schultz 1996). It has also been found that interven-
tions that target satellite cells at this age can have lifetime
effects on muscle growth and regenerative capacity
(Alexander et al. 2012; Briggs and Morgan 2013). The
myogenic program is under the regulation of a hierarchy of
transcription factors that govern satellite cell lineage fate
(Rudnicki et al. 2008) and these regulators have proven to
be prospective targets in promoting muscle growth (Bent-
zinger et al. 2012). It has recently been suggested that his-
tone deacetylase (HDAC) inhibitors may serve as a viable
tool to epigenetically alter satellite cell behavior (Moresi
et al. 2015; Sincennes et al. 2016). Butyrate is a potent and
broad-spectrum inhibitor of HDACs that has shown to be
beneficial at treating models of muscle pathology (Minetti
et al. 2006; Walsh et al. 2015a), but its effects on satellite
cell activity (Leibovitch et al. 1984; Johnston et al. 1992;
Iezzi et al. 2002) are controversial. Dietary butyrate, along
with tributyrin (a butyrate prodrug), has had positive
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effects on growth performance (as measured by growth rate
and efficiency of growth per unit of feed) (Piva et al. 2002,
2008; Yin et al. 2016), but these findings have been attribu-
ted to improved intestinal and digestive functions (Kotunia
et al. 2004; Le Gall et al. 2009; He et al. 2015; Huang et al.
2015; Dong et al. 2016). While the favorable use of dietary
butyrate seems clear, investigating whether it could be used
as a muscle growth promoter would have profound
impacts for human health and animal production.
Postnatal muscle growth and protein accretion are con-
sidered a hypertrophic event, as the number of muscle
fibers is set for most species at the time of birth (Rehfeldt
et al. 2000). The activity of satellite cells and their fusion
with growing muscle fibers govern the rate of muscle
growth and regeneration (Bentzinger et al. 2012). As
expected, due to their central role in lifetime muscle growth
and regeneration, the activity of satellite cells is tightly reg-
ulated via the expression of multiple transcription factors.
The paired-homeobox transcription factor Pax7 is univer-
sally expressed in satellite cells and allows for satellite cell
proliferation by preventing precocious differentiation
(Seale et al. 2000; Oustanina et al. 2004). Additionally,
Pax7 plays a role in the regulation of the downstream net-
work of myogenic regulatory factors (MRFs), specifically
myogenic differentiation 1 (MyoD) and myogenin (Olguin
and Olwin 2004). Changes in the Pax7 and MRF expression
patterns have been shown to regulate satellite cell commit-
ment fate, where a decrease in the Pax7:MyoD ratio leads
to terminal differentiation and myogenin expression
(Olguin et al. 2007). Upregulating Pax7 expression pre-
vents myogenin expression and allows for satellite cells to
either self-renew or enter into a quiescent state (Olguin and
Olwin 2004). Activation of MyoD is necessary for prolifer-
ating satellite cells to continue through their myogenic lin-
eage and to trigger terminal differentiation of myoblasts
(Megeney et al. 1996). The downstream target of MyoD,
myogenin, is necessary for fiber development embryonically
and for postnatal muscle growth (Hasty et al. 1993; Venuti
et al. 1995). Defects in the myogenin gene lead to pools of
undifferentiated satellite cells without an apparent effect on
the expression of MyoD. The alteration of the expression
and timing of these myogenic regulatory genes has been
presented as a practical means to increase muscle hypertro-
phy and regeneration (Blais et al. 2005; Moresi et al. 2015).
Epigenetic modifiers that inhibit HDACs in myoblasts
are gaining increasing interest in the fields of muscle
growth and regeneration (Sincennes et al. 2016). The ben-
eficial effects of HDAC inhibitors were initially described
as a method to treat neoplasms in humans and animal
models (see (Marks et al. 2000) for review). Only recently
has it been suggested that inhibiting HDACs could alter
myogenic programming (McKinsey et al. 2001). When
HDACs are expressed in undifferentiated satellite cells,
they bind to MyoD and the late-stage MRF, myogenin, is
not expressed (McKinsey et al. 2001). In culture, the
HDAC inhibitors have shown to increase myotube hyper-
trophy without an increase in satellite cell proliferation
(Iezzi et al. 2004). Sodium butyrate has also had positive
effects at influencing satellite cell fusion and increasing
myotube hypertrophy in culture (Iezzi et al. 2002).
The 4-carbon fatty acid, butyrate, is an inhibitor of many
HDACs (Candido et al. 1978; Davie 2003). Butyrate is pro-
duced naturally in the body from the fermentation of diet-
ary fiber and has been examined as an antitumor agent
since the 1970’s (Prasad 1980; Miller et al. 1987). There
have been conflicting reports on the effect of in vitro appli-
cation of butyrate on satellite cell behavior, from enhancing
muscle gene expression at different stages of myogenesis
(Iezzi et al. 2002) as well as inhibiting some parts of the
myogenic program (Fiszman et al. 1980; Leibovitch et al.
1984; Johnston et al. 1992). Within the animal production
industry, butyrate has been used as an aid in improving
intestinal health (He et al. 2015; Yin et al. 2016) and
growth performance through inclusion as the more palat-
able version, tributyrin, in the diet (Le Gall et al. 2009;
Huang et al. 2015). While muscle hypertrophy through
satellite cell programming has not been elucidated, butyrate
has had promising effects on muscle healing in some injury
models (Walsh et al. 2015a,b; Edwards and Butchbach
2016). Using neonatal and nursery piglets as model of rapid
muscle growth, we characterized the effects of butyrate on
satellite cell activity and their myogenic progression. We
hypothesize that supplementation of dietary tributyrin may
serve as an effective promoter of muscle growth through
enhanced satellite cell myogenesis.
Materials and Methods
Animals, diets, and experimental protocol
All animal protocols were approved by the Institutional
Animal Care and Use Committee of the University of
Maryland-College Park. In two animal feeding trials, we
investigated the effects of tributyrin supplementation on
muscle growth during both the neonatal (birth to 21-days
of age) and nursery (22–58-days of age) phases of growth.
During first animal feeding trial, tributyrin was supple-
mented at two different levels for 21 days to establish an
inclusion rate for the second animal feeding trial that
would extend into the nursery phase.
Study 1
To assess the impact of dietary tributyrin inclusion on
in vivo satellite cell programming, 30 cross-bred female pig-
lets (24  6 h old; 1.79  0.25 kg body weight) were
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assigned to one of three treatments (n = 10/group) and bal-
anced by body weight and litter. Piglets received either a
standard commercial milk replacer formula (Advance
Liqui-Wean, Milk Specialties Co., Dundee, IL) where 175 g
of dry milk replacer was reconstituted in water to 1 kg total
formula (C), or the milk replacer formula supplemented
with 0.25% (T0.25) or 0.5% (T0.5) total butyric acid in the
form of spray-dried tributyrin (AviPremiumD, Vetagro
SpA, Reggio Emilia, Italy). Tributyrin inclusion was on a
dry matter basis and diets across treatments were made
isoenergetic by the addition coconut oil. Piglets were housed
individually and received formula every 2 h (0900–2300) at
a limit-fed rate to match sow reared growth. One piglet
from T0.5 was removed from the study due to nontreat-
ment-related health issues. Body weight and feed intake
were recorded daily for the duration of the 21-day feeding
trial. Piglets were orally administered 20 mg/kg body weight
bromodeoxyuiridine (BrdU, Sigma Aldrich, St. Louis, MO)
18 h prior to euthanasia to determine in vivo proliferation
of satellite cells. Longissumus dorsi (LD) muscle was used
for all tissue analysis and satellite cell isolation.
After the 21-day neonatal feeding trial, LD was snap
frozen in liquid N2 for total DNA, protein abundance,
and gene expression analysis. Total muscle protein extrac-
tions were performed on ice in NP-40 buffer (20 mmol/L
Tris-HCl pH 8, 125 mmol/L NaCl, 1% NP-40, 2 mmol/L
ethylenediaminetetra-acetic acid (EDTA), 10% glycerol)
for 30 min containing cOmplete protease inhibitor and
PhosSTOP phosphatase inhibitor cocktails (Roche, Basel,
Switzerland). Insoluble material was pelleted by centrifu-
gation at 15,000g for 15 min at 4°C. Protein concentra-
tions were determined using BCA assays (ThermoFisher
Scientific, Waltham, MA).
Total DNA was extracted (DNeasy, Qiagen), fluores-
cently quantified (Quant-iT dsDNA assay kit) and com-
pared to the total protein content of the LD muscle. Total
RNA was isolated by homogenization using tri-reagent
(ThermoFisher Scientific) with phase separation achieved
by chloroform wash. RNA was precipitated with 70% etha-
nol and transferred to RNeasy spin column and purified
according to the manufacturers protocol (Qiagen).
For immunohistological analysis to determine fiber cross-
sectional area (FCA), LD samples were embedded in a 1:1
10% tragacanth gum OCT mixture and snap frozen in liquid
N2-cooled isopentane. Muscles sections (8 lm thick) were
cut and mounted on Superfrost Plus slides for immunos-
taining. FCA and fiber number were determined by anti-
dystrophin staining of the sarcolemma described below.
Study 2
We investigated the impact of continual dietary tributyrin
inclusion through the nursery phase of growth in a 2 9 2
factorial treatment structure. Piglets, 30 cross-bred females
(24  6 h old; 1.54  0.32 kg body weight), were fed
either a standard commercial milk replacer formula
(C, n = 15) or the milk replacer formula supplemented
with 0.5% total butyric acid in the form of spray-dried
tributyrin (T, n = 15) (as performed above) for 21 days.
Piglets were then weaned at 22-days of age and crossed into
their respective nursery phase dry diet: either commercial
dry nursery control diet (CC or TC; n = 6/group) (Tech-
Mix, Stewart, MN) or a control diet supplemented with
0.5% total butyric acid in the form of spray-dried tributyrin
(CT or TT; n = 9/group) (AviPremiumD, Vetagro SpA).
The control dry diet was supplemented with microencapsu-
lated palm oil to ensure equivalent energetics to the treat-
ment diet. Piglets were housed individually and fed
ad libitum and had free access to ad libitum water. Three
piglets (one from the TC group and two from the TT
group) were removed from the study for failing to wean.
After weaning, body weight and feed intake were recorded
weekly for the duration of the 37-day nursery feeding trial.
At the end of the 58-day feeding trial, LD muscle was
removed at the 12th rib to measure total loin area, evaluate
gene expression, and for immunohistochemical analysis to
determine FCA (as described above).
Satellite cell isolation and culture
Satellite cells from the neonatal piglets (Study 1) were iso-
lated according to a procedure modified from Doumit and
Merkel (1992) and Allen et al. (1997). Briefly, LD muscle
was excised from neonatal piglets after their prescribed
21-day feeding regimen, trimmed of connective tissue, and
minced with scissors. Tissue fragments were digested with
1.25 mg/mL protease from Streptomyces griseous (Pronase,
Sigma-Aldrich) for 1 h at 37°C. Satellite cells were disasso-
ciated from tissue fragments by trituration and differential
centrifugation. Cells were preplated on uncoated 15 cm tis-
sue culture dishes for 2 h (37°C, 5% CO2) in proliferative
growth media (PGM, DMEM + 10% FBS + antibi-
otics – 100 U/mL penicillin, 100 lg/mL streptomycin,
10 lg/mL gentamycin; Gibco) and then seeded on tissue-
cultured treated dishes coated with Poly-L-lysine (100 lg/
mL ddH2O, Sigma-Aldrich) and fibronectin (10 lg/mL
PBS, Sigma-Aldrich) in PGM until they reached ~50% con-
fluence (37°C, 5%CO2) or analyzed for in vivo prolifera-
tion (described below). Cells were then released with 0.05%
Trypsin (Gibco) and plated for our studies. Satellite cells
were identified by immunostaining for Pax7 (Seale et al.
2000; Zammit et al. 2006); cell isolations >95% Pax7+ were
used for our studies.
The effect of dietary tributyrin inclusion (0.25% and
0.5%, n = 10) effect on ex vivo satellite cell dynamics was
analyzed under proliferative and differentiative conditions.
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Satellite cells were seeded at 2500 cells/cm2 in PGM on to
plates coated with Poly-L-lysine and fibronectin. After a 24-
h attachment period, satellite cells were given 48 h in PGM
and then induced to differentiate (DM, DMEM + 2%
horse serum; Gibco + antibiotics) for an additional 72 h
with complete media changes daily. Total RNA was isolated
(RNeasy, Qiagen) at each 24 h time point for gene expres-
sion analysis. Satellite cell fusion was measured at 48 h
postdifferentiation by immunostaining.
In vitro proliferation was analyzed 24 h after plating
using the Click-iT EdU Alexa Fluor 488 imaging kit
(Molecular Probes). Satellite cells were pulsed for 2 h
with EdU and then fixed and stained according to the
manufacturer’s protocol. In vivo proliferation was assayed
by identifying proliferating cells with BrdU. Satellite cells
that had been direct-plated were fixed 4% paraformalde-
hyde and permeablized in 0.1% Triton X-100 (Sigma-
Aldrich) in PBS. Antigen retrieval was performed with
2 N HCl for 45 m at 37°C, acid was buffered for 10 m
with sodium tetraborate, and cells were blocked with 10%
goat serum in PBST. Satellite cells were incubated with
anti-BrdU (6 lg mL, Bio-Techne, Minneapolis, MN)
overnight at 4°C. Nuclei were visualized with 40,6-diami-
dino-2-phenylindole (DAPI) (Sigma-Aldrich). Images
were visualized on a Zeiss AxioObserver Z.1 and analyzed
with ZenPro automated image analysis suite (Carl Zeiss
AG, Oberkochen, Germany).
Western blot analysis
Protein from neonatal LD muscle homogenate was quan-
tified for total protein content by BCA assay (Pierce) and
subjected to western blotting. Equal amounts of protein
were electrophoresed and separated on 7.5% Mini-
PROTEAN TGX Precast Gels, transferred to an Immun-
Blot PVDF Membrane (Bio-Rad, Hercules, CA) and
stained with SimplyBlue SafeStain (ThermoFisher Scien-
tific) to ensure protein transfer. The membrane was then
incubated at 4°C overnight with the following the pri-
mary antibodies at a 1:1000 dilution, rabbit anti-phospho
mTOR (Ser-2448) and rabbit anti-phospho-AMPKa
(Thr-172) (Cell Signaling Technology, Danvers, MA).
Membranes were incubated for 1 h with horseradish per-
oxidase-conjugated goat anti-rabbit secondary antibody
(Jackson Immunoresearch, West Grove, PA), and devel-
oped with SuperSignal West Pico Chemiluminescent Sub-
strate Kit (ThermoFisher Scientific). Densitometry
analysis was performed using a ChemiDoc XRS system
and Image Lab Software (BioRad). Equal loading of pro-
teins was confirmed by reprobing with anti-AMPKa and
anti-mTOR antibodies (1:1000, Cell Signaling Technol-
ogy). Optical density was normalized to a pooled treat-
ment sample as a loading control.
Analysis of gene expression
Total RNA isolated from neonatal piglet LD muscle
and satellite cells were quantified using the Quant-iT
RiboGreen assay (Molecular Probes) according to the
manufacturer’s protocol. Harvested RNA was reverse
transcribed with the SuperScript IV First-Strand Synthe-
sis System, using equal concentrations of OligodT(20)
and random hexamers (Invitrogen) and treated with the
RNase H to ensure removal of RNA. The resulting
cDNA was quantified with the Quant-iT OligoGreen
assay (Molecular Probes). Total RNA and cDNA quan-
tification were detected on the Synergy HTX microplate
reader using the Gen 5.0 v3.0 software (BioTek Instru-
ments, Winooski, VT). cDNA was used for multiplex
qRT-PCR using Bio-Rad’s CFX96 Touch Real-Time
PCR Detection System and iQ Multiplex Powermix.
Analysis of gene expression (Pax7, MyoD, myogenin)
and amplification plots were executed with the CFX
Manager Software (version 3.1, Bio-Rad). Primers and
probes for the gene expression analysis were designed
by Integrated DNA Technologies (Coralville, IA)
(Table 1). After optimization, a 2:1 primer-to-probe
ratio was utilized for genes of interest while a 1:1 ratio
was used for the reference gene, RPL4. For each
assay, samples were amplified for 45 s at 60°C for 40
cycles.
Immunostaining
Satellite cell cultures and LD muscle sections were
immunostained to determine myotube formation and
FCA, respectively. Satellite cells were analyzed for purity
after isolation and for the expression of the contractile
protein myosin heavy chain (MyHC) after 48 h of dif-
ferentiation. Satellite cells were prefixed and nursery LD
muscle sections were postfixed in 4% paraformaldehyde
and permeablized with Triton X-100. Samples were
blocked with 10% goat serum in PBST (0.1% Tween-20
in PBS) for 1 h at room temperature. Cells and slides
were incubated overnight at 4°C with the primary anti-
bodies mouse monoclonal anti-Pax7 at 15 lg/mL
(Developmental Studies Hybridoma Bank, Iowa City,
IA) and mouse monoclonal anti-MyHC at 10 lg/mL
(Roche) or anti-dystrophin at 5 lg/mL (R&D Systems,
Minneapolis, MN), respectively. Primary antibodies were
removed and incubated with the secondary antibody
(AlexaFluor 488 goat anti-mouse IgG at 1:500 dilution,
Jackson Immunoresearch) in 5% goat serum for 1 h at
room temperature. Myotube formation and FCA images
were collected with Zeiss AxioObserver Z.1 and ana-
lyzed with ZenPro automated image analysis suite (Carl
Zeiss AG).
2018 | Vol. 6 | Iss. 10 | e13706
Page 4
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Dietary Tributyrin Promotes Muscle Growth R. L. Murray et al.
Statistical analysis
Study 1
The effects of tributyrin concentration on the response
variables were analyzed using an F-test in ANOVA (Graph-
Pad Prism 7, GraphPad Software, Inc., La Jolla, CA).
Study 2
Data were analyzed as a two-way ANOVA using the
PROC MIXED procedure in SAS (version 9.3; SAS Insti-
tute Inc., Cary, NC). Milk replacer treatment, dry nursery
dietary treatment, and their interaction were analyzed as
fixed effects while covariate(s) (initial body weight and/or
weaning weight) were analyzed as random effects in the
MIXED procedure of SAS (9.3).
In the case of a significant F-test, multiple mean compar-
isons were analyzed using a Tukey’s adjustment. A proba-
bility of P ≤ 0.05 was considered significant and a P-value
between 0.05 and 0.10 (0.05 < P ≤ 0.10) was considered a
trend. Data reported as least square means  SEM.
Results
Tributyrin inclusion on growth performance
Study 1
After the 21-day neonatal feeding trial, there was no effect
of treatment on final body weight, average daily gain
(ADG), or feed efficiency. There was a nonsignificant
decrease in feed intake in the T0.5 group. LD muscle was
harvested to analyze treatment effects on cellular mecha-
nisms of muscle growth rate. Tissue homogenate was
examined for total protein and DNA content to assess the
DNA:protein as a measure of myonuclear accretion
(Fig. 1). There was a significant increase in the DNA:
protein in the T0.5 group (5.5  0.5 mg/g, DNA/
protein) compared to the other two treatment diets
(T0.25 = 4.1  0.4 mg/g; C = 3.8  0.5 mg/g) (P < 0.05).
There was no treatment effect on the ratio of phosphory-
lated to total mTOR or AMPKa protein expression
revealed by western blotting (data not shown). Based on
these findings, we supplemented the milk replacer with
0.5% tributyrin for the nursery feeding trial in order to
investigate the potential for enhanced muscle growth.
Study 2
At the end of the 58-day feeding trial (neonatal + nurs-
ery), there was a significant increase in final body weight
and ADG in animals that received tributyrin in the milk
replacer before weaning (TT and TC) compared to ani-
mals that received control milk replacer diet (CC and
CT) (P < 0.05; Table 2). After completion of the trial,
piglets treated with tributyrin during the neonatal phase
(D1–D21) weighed 8% more than the control piglets,
30.8  0.6 kg and 28.4  0.6 kg, respectively, and had a
9% increase in their ADG (659  17 g compared to the
control 603  16 g). There were no treatment effects seen
in final body weight or feed efficiency between the four
nursery diet treatment comparisons. Loin area and FCA
from the piglets treated with tributyrin during the neona-
tal phase was significantly larger compared to those pig-
lets that did not receive tributyrin in their milk replacer
(P < 0.05; Fig. 2A). At the end of the 58-day feeding trial,
piglets supplemented with tributyrin during the neonatal
period had a loin area of 25.3  0.7 cm2 compared to
the control piglets, 22.7  0.6 cm2. Similarly, muscle his-
tology sections stained with anti-dystrophin (Fig. 2C)
revealed a 25% increase in the FCA of TT and TC piglets
(1790  120 lm2) compared to CC and CT piglets
(1420  60 lm2) (P < 0.05; Fig. 2B).
Satellite cell myogenesis
Satellite cells were harvested from neonatal piglets after
21 days of milk feeding with (T0.25 or T0.5) or without
(C) tributyrin supplementation. There was no treatment
Table 1. Primers and probe sequences used for gene expression analysis by multiplex quantitative RT-PCR.
Gene symbol Gene ID Primer sequence 50-30 Probe and sequence 50-30
PAX7 100625823 F: CAGCAAGCCCAGACAGG
R: TCGGATCTCCCAGCTGAA
(HEX): TTGAGGAGTACAAGAGGGAGAACCCA
MYOD1 407604 F: CCGACGGCATGATGGATTATAG
R: CGACACCGCAGCATTCTT
(FAM): AATAGGTGCCGTCGTAGCAGTTCC
MYOG 497618 F: AGTGAATGCAGTTCCCACAG
R: AGGTGAGGGAGTGCAGATT
(Texas Red): CAACCCAGGGGATCATCTGCTC
RPL4 100038029 F: TGGTGGTTGAAGATAAAGTTGAAAG
R: TGAGAGGCATAAACCTTCTTGAT
(Cy5): AACCAAGGAGGCTGTTCTGCTTCT
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effect on in vivo or in vitro satellite cell proliferation, as
assessed by BrdU and EdU staining, respectively. Satellite
cells were cultured under proliferative conditions until
confluent and induced to differentiate with gene expres-
sion analyzed every 24 h to determine myogenic progres-
sion. Throughout differentiation, there was an average
sevenfold (T0.25; P < 0.01) and fourfold (T0.5; P < 0.05)
increase in the expression of the late-stage MRF myogenin
in satellite cells from those animals treated with tributyrin
compared to control animals (Fig. 3). There was not a
significant change in Pax7 or MyoD expression in satellite
cells from treated animals compared to the control ani-
mals (data not shown). When LD muscle sections of
neonatal piglets from study 1 were analyzed for myogenic
gene expression, a similar trend was revealed. Myogenin
was upregulated 1.4-fold in the T0.25 group compared to
the control (P < 0.10) without changes in Pax7 or MyoD
expression (Fig 4). To further examine the effect of tribu-
tyrin on ex vivo satellite cell myogenesis, myotube forma-
tion was determined 48 h after satellite cells were induced
to differentiate (Fig. 5A). There was a 1.7-fold increase in
the number of MyHC+-fused nuclei from T0.25 animals
compared with the control animals (P < 0.05; Fig. 5B).
Discussion
The benefits of dietary inclusion of butyrate or tributyrin
on animal health (Galfi and Bokori 1990; Piva et al. 2002,
2008; Hou et al. 2014) and growth performance (Leeson
et al. 2005; Lu et al. 2012; Piva et al. 2016; Bedford et al.
2017) have been demonstrated; however, the role that
butyrate has on the mechanisms behind muscle growth
has yet to be elucidated. In the present study, we exam-
ined the ability of dietary tributyrin to enhance muscle
hypertrophy and its effect on satellite cell programming.
Our results indicate that early-life supplementation with
tributyrin may promote muscle growth through increased
satellite cell myogenic potential.
The objective of study 1 was to assess what dietary
tributyrin inclusion level is necessary to impact muscle
Figure 1. Total protein and DNA were extracted from Longissimus dorsi muscle of piglets fed either a basal milk replacer (n = 10), or the milk
replacer supplemented with 0.25% (T0.25, n = 10) or 0.5% (T0.5, n = 9) tributyrin for 21 days. (A) Protein and DNA concentrations in LD
muscle tissue. (B) Bar graph depicting the ratio of DNA:Protein. Bars not sharing a common superscript differ significantly, P < 0.05.




CC CT TC TT Milk Dry Milk 9 dry1
n 6 9 5 7
Initial body weight (kg) 1.6 1.5 1.4 1.6 0.06 – – –
Weaning weight (kg) 6.4 6.3 5.9 6 0.1 0.11 – –
Final body weight (kg) 29.6 29.3 30.4 29.6 1.1 0.03 0.66 1.00
Postweaning average daily gain (g) 627 618 658 641 28 0.03 0.66 0.98
Feed efficiency after weaning3 1.41 1.41 1.37 1.41 0.04 0.37 0.52 0.99
1
Value represented as least square means of main effects.
2
CC (milk replacer control; nursery control), CT (milk replacer control; nursery diet with tributyrin), TC (milk replacer with tributyrin; nursery
control diet), and TT (milk replacer with tributyrin; nursery diet with tributyrin).
3
Feed efficiency = Average daily feed intake/average daily gain (day 22–58).
4
Effect of tributyrin inclusion in the milk replacer, in the nursery diet, and their interaction.
Bold values indicate the level of significance.
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growth parameters. Also, satellite cells were harvested
from the neonatal animals and we investigated the effect
of tributyrin supplementation on in vivo and ex vivo
satellite cell programming. At the completion of study 1,
the results of tributyrin inclusion during neonatal feeding
were suggestive that an inclusion rate of tributyrin at
0.5% in study 2 may improve muscle growth through
enhanced myonuclear accretion.
Studies have revealed the beneficial performance and
growth effects of butyrate and tributyrin supplementation,
all the while linking these positive results to an enhanced
trophic status of the GI tract. Tributyrin provides an effi-
cient means to deliver butyrate to systemic circulation for
a sustained duration (Egorin et al. 1999). Our results

































Figure 2. At 58 days of age, cross-section of Longissimus dorsi (LD) muscle was taken at the 12th rib and utilized for immunohistochemical
analysis to determine fiber cross-sectional area (FCA). Values depicted are based off pooled neonatal control (C, n = 12) or tributyrin
(T, n = 12) treatment groups. (A) The cross-sectional area of the LD at the 12th rib (loin eye). (B) LD muscle FCA as determined by
immunohistochemistry. (C) Immunohistochemical analysis of FCA of the LD muscle. Muscle fibers were cryosectioned and stained with
anti-dystrophin to visualize sarcolemma (green), >400 fibers/animal were counted using Zeiss ZEN Pro automated image analysis. Nuclei were






























Figure 3. Myogenin gene expression in cultured satellite cells from
neonatal piglets treated with either control diet (n = 10), or a control
diet supplemented with 0.25% (T0.25, n = 10) or 0.5% (T0.5, n = 9)
tributyrin for 21 days. After induced to differentiate, total RNA was
harvested and myogenin expression was quantified by RT-PCR.
Expression was normalized within animal to RPL4 at each time point.
Bars not sharing superscripts differ significantly, P < 0.05.
Figure 4. Total RNA was harvested from Longissiumus dorsi
muscle from neonatal piglets treated with either control diet
(n = 10), or a control diet supplemented with 0.25% (T0.25, n = 10)
or 0.5% (T0.5, n = 9) tributyrin for 21 days. Gene expression of
Pax7 and the myogenic regulatory factors MyoD and myogenin
(MyoG) was measured by quantitative RT-PCR. Expression was
normalized within animal to RPL4. Bars not sharing superscripts
showed a trend, P < 0.10.
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a direct effect on satellite cell myogenesis. Our primary
objective was to determine the effect of tributyrin supple-
mentation on muscle growth at different stages of early
life (preweaning/postweaning). Postnatal muscle growth
and regeneration are dependent upon satellite cell activa-
tion and proliferation followed by consequent differentia-
tion and fusion into the growing myofiber (Davis and
Fiorotto 2009). After being fed a milk replacer supple-
mented with tributyrin for 21 days, piglets had an
increase in total DNA content and the DNA:protein.
While there were no differences in weight gain at the end
of the neonatal feeding trial, an increase of almost 40% in
total DNA content and the DNA:protein ratio suggests an
amplification of myonuclear accretion and a propensity
for enhanced muscle growth (Brown and Stickland 1994).
Secondary to myonuclear accretion is the subsequent pro-
tein synthesis and muscle fiber hypertrophy. During the
neonatal feeding trial, piglets were limit-fed to match nor-
mal, sow reared growth. Given this feeding regimen, it is
possible that the piglets were limited in amino acid avail-
ability for maximal protein synthesis. While it seems that
tributyrin supplementation altered satellite cell behavior,
there did not appear to be any changes in the mTOR sig-
naling pathway, which governs protein synthesis (Bodine
et al. 2001) and has been shown to regulate satellite cell
fusion machinery (Sun et al. 2010). In intestinal epithelial
cells, butyrate has been shown to reduce the amount of
phospho-AMPK which is known to inhibit mTOR (Yan
and Ajuwon 2017); however, we did not see any differ-
ences by tributyrin treatment. The time required for the
accumulated myonuclei to synthesize protein and con-
tribute to the growing fiber may not have been sufficient
to realize increased muscle hypertrophy. These results
imply that prolonged, postweaning ad libitum feeding in
the nursery would be necessary to assess whether dietary
tributyrin inclusion would effectively promote muscle
growth.
Neonatal piglets were once again fed a milk replacer
supplemented with 0.5% tributyrin and then weaned into
the nursery on a dry diet supplemented with 0.5% tribu-
tyrin. After the nursery feeding trial, animals that had























Figure 5. Satellite cells harvested from neonatal piglets treated with a control milk replacer diet (n = 10), or a control diet supplemented with
0.25% (T0.25, n = 10) or 0.5% (T0.5, n = 9) tributyrin for 21 days were induced to differentiate for 48 h. (A) Representative images of
immunofluorescently stained myotubes with anti-MyHC (green). Nuclei were visualized with DAPI and counted using Zeiss ZEN Pro automated
image analysis. (B) Bar graph depicting the fusion percentages (≥2 nuclei expressing MyHC/total nuclei) in satellite cells from those animals
treated with either control diet, or a control diet supplemented with 0.25% (T0.25) or 0.5% (T0.5) tributyrin. Bars not sharing superscripts differ
significantly, P < 0.05.
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significant increase in ADG and final body weight. Inter-
estingly, there was not a treatment effect with regards to
nursery diet. These results are similar to those obtained
by Le Gall et al. (2009), where those animals that had
received butyrate during milk feeding had enhanced
growth, but the authors again attribute the increase in
growth to increased feed digestibility and increased feed
intake. Our data showed no significant differences in feed
efficiency; however, animals receiving tributyrin had a
reduction in feed consumed, but the differences did not
rise to the level of significance. Butyrate supplementation
has been associated with decreased feed intake while on
treatment diets in other studies (Leeson et al. 2005; Hou
et al. 2014); there is also a body of evidence linking mild
ketosis with decreased appetite and increased satiety
through unknown mechanisms (Puchalska and Crawford
2017). It may be that exogenous supplementation of
butyrate induces a mild ketosis of which decreases overall
feed intake and may confound the beneficial effects of
tributyrin supplementation preweaning. However, the
positive effects of tributyrin supplementation in the piglet
milk replacer resulting in an increase in growth perfor-
mance (Final BW = 8%, ADG = 9%) and muscle growth
(Loin area = 11%, FCA = 25%) were unmistakable after
piglets had reached the end of the nursery feeding.
We found that the hypertrophic benefit of tributyrin
supplementation altered satellite cell behavior and
enhanced terminal differentiation. The increase in myo-
genin expression found in the LD muscle of the tributyrin-
treated neonatal piglets may be indicative of satellite cells
beginning to differentiate quicker and fuse into present
myofibers (Wang and Rudnicki 2012). This was marked by
the enhanced terminal differentiation seen in the ex vivo
satellite cell cultures. Satellite cells from those piglets trea-
ted with tributyrin (both T0.25 and T0.5) had an increase in
the proportion of those cells expression of the contractile
protein MyHC. This was associated with the increased
upregulation of myogenin after satellite cell cultures were
induced to differentiate. Although there were no noticeable
treatment effects on either in vivo or ex vivo satellite cell
proliferation, this is noteworthy due to butyrate’s ability to
halt cell proliferation seen in satellite cell culture experi-
ments (Leibovitch et al. 1984; Iezzi et al. 2002). These
results indicate that the increased myonuclear content may
not come from a significant increase in the proliferative
potential of satellite cells, but rather a temporal acceleration
of the differentiation process. The lack of differences seen
in the in vivo proliferation of satellite cells also suggests that
tributyrin’s effect on satellite cell behavior may be most
salient at the earliest stages of life.
The differences in gene expression and myogenic
potential displayed in the satellite cell cultures from the
tributyrin-treated groups also support the notion that
tributyrin, and its ensuing metabolite butyrate, may be
serving as an epigenetic modifier of satellite cell behavior
(Sincennes et al. 2016). The HDAC inhibitory properties
of butyrate may be leading to improved muscle differenti-
ation through histone modifications that result in
increased myogenin expression. This compliments the
findings that decreased HDAC activity has resulted in
increased acetylation of nonhistone proteins, such as
MyoD, which is necessary for myogenesis and promotes
myogenic differentiation (Mal et al. 2001; Ma et al. 2005;
Duquet et al. 2006). In this regard, it appears that dietary
tributyrin may serve as a viable inhibitor of HDACs for
pharmacological manipulation of myogenic genes.
Using a neonatal piglet model of muscle growth, we
have shown that early dietary inclusion of the butyrate
prodrug, tributyrin, resulted in an increase in muscle
mass by muscle fiber hypertrophy. Our findings also indi-
cate that the accelerated muscle growth triggered by
tributyrin is due to increased myonuclear accretion and
subsequent myofiber hypertrophy. Supplementing tribu-
tyrin in the milk replacer formula of neonatal piglets
resulted in enhanced muscle growth driven by enhanced
satellite cell myogenesis. Contradictory with some previ-
ous findings (Le Gall et al. 2009; Piva et al. 2016), dietary
supplementation of tributyrin to the older weaned pigs
did not increase muscle growth or improve growth per-
formance. This suggests that there is a window of oppor-
tunity to utilize tributyrin to impact muscle growth via
alterations in satellite cell activity and that early-life inter-
ventions with tributyrin may be able to ameliorate deficits
in muscle growth caused by limitations in the myogenic
activity of satellite cells.
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